ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
0.00
0.00%
US Tech 100
21,214.46
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,367.15
-1.22%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Fibrogen Inc (0IL8) 시세

Fibrogen Inc

Fibrogen Inc (0IL8)

LSE
52.55
0.00
(0.00%)
마감 23 1월 1:30AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
52.55
매수가
0.00
매도가
0.00
거래량
53,907
0.00 일간 변동폭 0.00
52.55 52주 범위 52.55
market_cap
5.168B
전일 종가
52.55
개장가
-
최근 거래 시간
400
@
0.49365
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
23,458
발행 주식
98,340,000
배당수익률
-
주가수익률
-0.17
주당순이익(EPS)
-2.89
매출
147.75M
순이익
-284.23M

Fibrogen Inc 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.fibrogen.com
본부
Wilmington, Delaware, USA
설립됨
-
Fibrogen Inc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker 0IL8. The last closing price for Fibrogen was US$52.55. Over the last year, Fibrogen shares have traded in a share price range of US$ 52.55 to US$ 52.55.

Fibrogen currently has 98,340,000 shares in issue. The market capitalisation of Fibrogen is US$5.17 billion. Fibrogen has a price to earnings ratio (PE ratio) of -0.17.

0IL8 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10052.5552.5552.55551752.55DE
40052.5552.5552.555772252.55DE
120052.5552.5552.552345852.55DE
260052.5552.5552.554361452.55DE
520052.5552.5552.555253152.55DE
1560052.5552.5552.552137152.55DE
2600052.5552.5552.551296652.55DE

0IL8 - Frequently Asked Questions (FAQ)

What is the current Fibrogen share price?
The current share price of Fibrogen is US$ 52.55
How many Fibrogen shares are in issue?
Fibrogen has 98,340,000 shares in issue
What is the market cap of Fibrogen?
The market capitalisation of Fibrogen is USD 5.17B
What is the 1 year trading range for Fibrogen share price?
Fibrogen has traded in the range of US$ 52.55 to US$ 52.55 during the past year
What is the PE ratio of Fibrogen?
The price to earnings ratio of Fibrogen is -0.17
What is the cash to sales ratio of Fibrogen?
The cash to sales ratio of Fibrogen is 0.33
What is the reporting currency for Fibrogen?
Fibrogen reports financial results in USD
What is the latest annual turnover for Fibrogen?
The latest annual turnover of Fibrogen is USD 147.75M
What is the latest annual profit for Fibrogen?
The latest annual profit of Fibrogen is USD -284.23M
What is the registered address of Fibrogen?
The registered address for Fibrogen is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Fibrogen website address?
The website address for Fibrogen is www.fibrogen.com
Which industry sector does Fibrogen operate in?
Fibrogen operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

토론

전체 피드 보기
ThoroughBread ThoroughBread 5 분 전
SFIO .0028 sleeper.
SFIO
glens0 glens0 6 분 전
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 8 분 전
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 8 분 전
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 9 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 9 분 전
KPIFF
wadegarret wadegarret 10 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 10 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 11 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 12 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 12 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 13 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 13 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 15 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 15 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 16 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 17 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 17 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 18 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 20 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 21 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 21 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 22 분 전
Whats 305
RNVA

최근 히스토리

LSE
0IL8
Fibrogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유